checkAd

Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform

Nachrichtenquelle: Business Wire (engl.)
08.04.2021, 22:07  |  105   |   |   

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will present new data in scientific posters to be presented at the American Association for Cancer Research (AACR) Annual Meeting 2021, which will be held online, April 10-15, 2021 and May 17-21, 2021.

These abstracts showcase data from ImmunoID NeXT, the first platform to enable comprehensive analysis of both a tumor and its immune microenvironment from a single sample. The ImmunoID NeXT Platform can be used to investigate the key tumor- and immune-related areas of cancer biology, consolidating multiple oncology biomarker assays into one and maximizing the biological information that can be generated from a precious tumor specimen.

Following are details and links to the scientific posters that will be presented at the online meeting.

Poster Number, Session Category and Session Title

 

Title & Presenter

 

Date

 

Location

399

Clinical Research (Excluding Trials)

 

Biomarkers Predictive of Therapeutic Benefit

Pan-cancer survey of HLA loss of heterozygosity using a robustly validated NGS-based machine learning algorithm

 

Presenter: Rachel Marty Pyke, PhD

 

April 10, 2021

Online

555

Clinical Research (Excluding Trials)

 

Liquid Biopsies: Circulating DNA

Longitudinal exome-scale liquid biopsy monitoring of evolving therapeutic resistance mechanisms in head and neck squamous cell carcinoma patients receiving anti-PD-1 therapy

 

Presenter: Charles Abbott, PhD

April 10, 2021

Online

1898

Immunology
Tumor

 

Antigenicity/Processing and Presentation

Accurate modeling of antigen processing and MHC peptide presentation using large-scale immunopeptidomes and a novel machine learning framework

Seite 1 von 2
Personalis Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen
Wertpapier



0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will present new data in scientific posters to be presented at the American Association for Cancer Research (AACR) Annual Meeting 2021, which …

Nachrichten des Autors

Titel
Titel
Titel
Titel